Finally, FDA moved in 2026 to tighten the bulk-substance pathway for large-scale compounding
If you have been using a 0.3 mL (30-unit) syringe, you will need to switch to a 0.5 mL syringe at this point
For perspective, prior to 2023, the top-selling drugs were largely immunology or oncology biologics (like Humira, Keytruda, Eliquis), but by mid-2024, the list transformed GLP-1 agonists entered the top ranks
The products arrived on time, were easy to use and a representative answered my questions
Association of probable post-traumatic stress disorder with dietary pattern and gut microbiome in a cohort of women
Lather on scalp (not lengths)